ロード中...
Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea
PURPOSE: Epidermal growth factor receptor (EGFR) exon 20 insertion mutations account for approximately 4% of all EGFR mutations. Given the rarity of this mutation, its clinical outcomes are not fully established. MATERIALS AND METHODS: Between 2009 and 2017, non-small cell lung cancer (NSCLC) patien...
保存先:
| 出版年: | Cancer Res Treat |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Korean Cancer Association
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6473281/ https://ncbi.nlm.nih.gov/pubmed/30049203 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2018.151 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|